Astrazeneca AZN
NYSE AZN
$163.66 +3.49 (+2.18%)
As of: Sep 14, 2026 · 3:07 PM EDT

Astrazeneca (AZN) Cash from Investing Activities Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Asml Holding 618.04 Bn 602.06 Bn 5.90 Bn -
2 Hsbc Holdings 362.64 Bn 362.64 Bn - -
3 General Electric 329.87 Bn 320.52 Bn 6.95 Bn -31.20%
4 Astrazeneca 253.67 Bn 248.39 Bn 12.86 Bn -77.58%
5 Citigroup 228.64 Bn -2,073.66 Bn 24.75 Bn -
6 Bhp 216.08 Bn 197.54 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.34 Bn 132.31 Bn - -
10 Hdfc Bank 117.87 Bn 80.72 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -77.58%
Mar 31, 2026 -12.88%
Jun 30, 2025 -38.12%
Mar 31, 2025 -95.38%
Dec 31, 2024 -8.96%
Sep 30, 2024 47.50%
Jun 30, 2024 -130.02%
Mar 31, 2024 -85.16%
Jun 30, 2023 -76.66%
Mar 31, 2023 -419.80%
Jun 30, 2022 10.53%
Mar 31, 2022 -35.94%
Dec 31, 2021 -43.98%
Sep 30, 2021 -320.24%
Jun 30, 2021 -34.96%
Mar 31, 2021 26.68%
Dec 31, 2020 27.22%
Sep 30, 2020 -20.08%
Jun 30, 2020 39.62%
Mar 31, 2020 27.27%